Clinician's Brief: The Podcast

Exploring an Innovative Drug Class in Feline Diabetes with Dr. Byers

Episode Summary

An innovative, noninsulin drug option has arrived for the management of feline diabetes: the sodium-glucose cotransporter-2 inhibitor. In this episode of Clinician’s Brief Partner Podcast, host Dr. Beth invites Dr. Christopher Byers to discuss this novel option and how it is changing clinical strategies in the approach to feline diabetes. From case selection and monitoring to pet owner education and more, this episode will answer all your FAQs and leave you feeling ready to implement the latest pharmaceutical in practice. Sponsored by Boehringer Ingelheim Resource: SENVELGOClinic.com Contact us: Podcast@briefmedia.com Where to find us: Cliniciansbrief.com/podcasts Facebook.com/clinciansbrief Twitter: @cliniciansbrief Instagram: @clinicians.brief The Team: Beth Molleson, DVM - Host Sarah Pate - Producer & Project Manager, Brief Studio Randall Stupka - Podcast Production & Sound Editing

Episode Notes

An innovative, noninsulin drug option has arrived for the management of feline diabetes: the sodium-glucose cotransporter-2 inhibitor. In this episode of Clinician’s Brief Partner Podcast, host Dr. Beth invites Dr. Christopher Byers to discuss this novel option and how it is changing clinical strategies in the approach to feline diabetes. From case selection and monitoring to pet owner education and more, this episode will answer all your FAQs and leave you feeling ready to implement the latest pharmaceutical in practice.

Sponsored by Boehringer Ingelheim

Resource:

• SENVELGOClinic.com

Contact us:

• Podcast@briefmedia.com

Where to find us:

• Cliniciansbrief.com/podcasts
• Facebook.com/clinciansbrief
• Twitter: @cliniciansbrief
• Instagram: @clinicians.brief

The Team:

• Beth Molleson, DVM - Host
• Sarah Pate - Producer & Project Manager, Brief Studio
• Randall Stupka - Podcast Production & Sound Editing